Amivantamab 350mg/7ml solution for infusion vials

SNOMED code
40388311000001108
Active compound
Amivantamab
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
7 ml, vial
Ingredients
Amivantamab — 50 mg / 1 ml based on ingredient substance
Form & Route
solutioninfusion.intravenous
Solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Rybrevant 350mg/7ml concentrate for solution for infusion vials (Janssen-Cilag Ltd)

in short Rybrevant 350mg/7ml concentrate for inf vials

Rybrevant 350mg/7ml concentrate for solution for infusion vials

SNOMED code
40384111000001100
Supplier
Janssen-Cilag Ltd
Licensed as
Medicines - MHRA/EMA
EMA (European Medicines Agency) Monitoring
Yes, black triangle marked
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Rybrevant 350mg/7ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) 1 vial
40384211000001106   ref. pack
💯 Available

Legal category: POM
5012674904183
NHS Indicative Price
£1,079
• Hospital
  • • Prescription Charges

Reference packs

Amivantamab 350mg/7ml solution for infusion vials 1 vial
SNOMED code
40384011000001101
Quantity and unit
1 vial
Packs